These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31393941)

  • 1. CRISPR-Cas9 mediated CD133 knockout inhibits colon cancer invasion through reduced epithelial-mesenchymal transition.
    Li W; Cho MY; Lee S; Jang M; Park J; Park R
    PLoS One; 2019; 14(8):e0220860. PubMed ID: 31393941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enrichment of cancer stem-like cells by the induction of epithelial-mesenchymal transition using lentiviral vector carrying E-cadherin shRNA in HT29 cell line.
    Saltanatpour Z; Johari B; Alizadeh A; Lotfinia M; Majidzadeh-A K; Nikbin B; Kadivar M
    J Cell Physiol; 2019 Dec; 234(12):22935-22946. PubMed ID: 31111504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of CD133 overexpression on the epithelial-to-mesenchymal transition in oral cancer cell lines.
    Moon Y; Kim D; Sohn H; Lim W
    Clin Exp Metastasis; 2016 Jun; 33(5):487-96. PubMed ID: 27137188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of microRNA-194 suppresses the epithelial-mesenchymal transition in targeting stem cell transcription factor Sox3 in endometrial carcinoma stem cells.
    Gong B; Yue Y; Wang R; Zhang Y; Jin Q; Zhou X
    Tumour Biol; 2017 Jun; 39(6):1010428317706217. PubMed ID: 28618953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [TNF-α activates Wnt signaling pathway to promote the invasion of human colon cancer stem cells].
    Wei X; Li X; Kong F; Ma L; Sui Y; Chen D; Xu F
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Nov; 34(11):982-988. PubMed ID: 30591106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.
    Zhou JY; Chen M; Ma L; Wang X; Chen YG; Liu SL
    Oncotarget; 2016 Feb; 7(7):7657-66. PubMed ID: 26840024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer.
    Yang Y; Wang G; Zhu D; Huang Y; Luo Y; Su P; Chen X; Wang Q
    Int J Oncol; 2017 Aug; 51(2):515-524. PubMed ID: 28627611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-κB signaling pathway.
    Shen T; Yang Z; Cheng X; Xiao Y; Yu K; Cai X; Xia C; Li Y
    Oncol Rep; 2017 Apr; 37(4):2095-2100. PubMed ID: 28259918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-targeted microbubble destruction-mediated downregulation of CD133 inhibits epithelial-mesenchymal transition, stemness and migratory ability of liver cancer stem cells.
    Liu YM; Li XF; Liu H; Wu XL
    Oncol Rep; 2015 Dec; 34(6):2977-86. PubMed ID: 26370320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M1 Macrophages Promote TRAIL Expression in Adipose Tissue-Derived Stem Cells, Which Suppresses Colitis-Associated Colon Cancer by Increasing Apoptosis of CD133
    Eom YW; Akter R; Li W; Lee S; Hwang S; Kim J; Cho MY
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer.
    Horst D; Scheel SK; Liebmann S; Neumann J; Maatz S; Kirchner T; Jung A
    J Pathol; 2009 Dec; 219(4):427-34. PubMed ID: 19621338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6 promotes growth and epithelial-mesenchymal transition of CD133+ cells of non-small cell lung cancer.
    Lee SO; Yang X; Duan S; Tsai Y; Strojny LR; Keng P; Chen Y
    Oncotarget; 2016 Feb; 7(6):6626-38. PubMed ID: 26675547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long intergenic non-protein-coding RNA 1567 (LINC01567) acts as a "sponge" against microRNA-93 in regulating the proliferation and tumorigenesis of human colon cancer stem cells.
    Yu X; Mi L; Dong J; Zou J
    BMC Cancer; 2017 Nov; 17(1):716. PubMed ID: 29110645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bmi-1 promotes the invasion and migration of colon cancer stem cells through the downregulation of E-cadherin.
    Zhang Z; Bu X; Chen H; Wang Q; Sha W
    Int J Mol Med; 2016 Oct; 38(4):1199-207. PubMed ID: 27600678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells.
    Maeda K; Ding Q; Yoshimitsu M; Kuwahata T; Miyazaki Y; Tsukasa K; Hayashi T; Shinchi H; Natsugoe S; Takao S
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27367674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMP-2 induces motility and invasiveness by promoting colon cancer stemness through STAT3 activation.
    Kim BR; Oh SC; Lee DH; Kim JL; Lee SY; Kang MH; Lee SI; Kang S; Joung SY; Min BW
    Tumour Biol; 2015 Dec; 36(12):9475-86. PubMed ID: 26124007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.
    Zhang Y; Wei J; Wang H; Xue X; An Y; Tang D; Yuan Z; Wang F; Wu J; Zhang J; Miao Y
    Oncol Rep; 2012 May; 27(5):1599-605. PubMed ID: 22322379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells.
    Huo W; Zhao G; Yin J; Ouyang X; Wang Y; Yang C; Wang B; Dong P; Wang Z; Watari H; Chaum E; Pfeffer LM; Yue J
    J Cancer; 2017; 8(1):57-64. PubMed ID: 28123598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated STAT3 may participate in tumor progression through increasing CD133/survivin expression in early stage of colon cancer.
    Li W; Lee MR; Kim T; Kim YW; Cho MY
    Biochem Biophys Res Commun; 2018 Feb; 497(1):354-361. PubMed ID: 29432737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CRISPR/Cas system inhibited the pro-oncogenic effects of alternatively spliced fibronectin extra domain A via editing the genome in salivary adenoid cystic carcinoma cells.
    Wang HC; Yang Y; Xu SY; Peng J; Jiang JH; Li CY
    Oral Dis; 2015 Jul; 21(5):608-18. PubMed ID: 25684411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.